| |
Raza, A., Ruonamici, S., Lisak, L., et.al (2004) Arsenic trioxide and thalidomide combination produces multilineage haematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leukemia Resea
Thalidomide and Myeloma
McBride WG. (1961) Thalidomide and congenital malformations. Lancet, 2: 1358.
Thalidomide and Myeloma
Sampaio, E.P., et al. (1991) Thalidomide selectively inhibits tumour necrosis factor alpha production by stimulated humanmonocytes. J. Exp. Med. 173, 699-703
Thalidomide and Myeloma
Capitosti, S.M., Hansen, T.P., Brown, M.L., (2004) Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer, Bioorganic and Medicinal Chemistry, 12:327-336
Thalidomide and Myeloma
Fu, L.M., Fu-Liu, C.S., (2002) Thalidomide and tuberculosis, Int J Tuberc Lung Dis. 6:569-572
Thalidomide and Myeloma
|
|